Transcelerate Biopharma Inc
Public records raise at least one point you should look into before giving.
What it says it does
THE ORGANIZATION'S MISSION IS TO COLLABORATE ACROSS THE GLOBAL BIOPHARMACEUTICAL R&D COMMUNITY TO IDENTIFY, DESIGN AND FACILITATE IMPLEMENTATION OF SOLUTIONS DESIGNED TO DRIVE THE EFFICIENT, EFFECTIVE AND HIGH QUALITY DELIVERY OF NEW MEDICINES.
- Income
- $34.2 million
- Spending
- $33.0 million
- Employees
- 35
- Volunteers
- 28
- Highest pay
- $1.2 million, ceo
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. How we rate
Financial health
We do not score finances when yearly spending is very small or the return has too little detail. The ratios stop meaning much at that size.
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. How we rate
Governance
This return does not answer enough of the governance questions to score.
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (1)
- $22.0 million spent. IN 2025, TRANSCELERATE DELIVERED PRACTICAL SOLUTIONS TO SIMPLIFY TRIAL DESIGN AND EXECUTION, STRENGTHEN QUALITY, AND REDUCE BURDEN ACROSS THE R&D ECOSYSTEM. THE APPROACH COMBINED RAPID IMPROVEMENTS FOR IMMEDIATE IMPLEMENTATION WITH LONG-TERM SOLUTIONS TO HELP PROMISING THERAPIES REACH PATIENTS MORE QUICKLY AND SAFELY.THE ORGANIZATION LED 12 ACTIVE INITIATIVES IN 2025 AND LAUNCHED MORE THAN 60 TOOLS AND SOLUTIONS ACROSS THREE AREAS OF FOCUS:- TRANSFORMING CONNECTIVITY: REDEFINING HOW RESEARCH AND CARE INTERACT- INFORMATION SHARING AND REUSE: LEVERAGING EXISTING DATA FOR FASTER DEVELOPMENT- INNOVATIVE TRIAL DESIGN: PUTTING PATIENTS AT THE HEART OF CLINICAL TRIALS.HIGHLIGHTS OF 2025 PROGRESS:- DIGITAL DATA FLOW (DDF): SPONSORS CONTINUED TO ADOPT DDF WHILE GROWING INTEREST FROM SOLUTION PROVIDERS SHOWED THAT DIGITAL PROTOCOL INNOVATION IS MOVING FROM EARLY PILOT TO EVERYDAY PRACTICE.- ICH E6(R3) SUPPORT: FIFTEEN PRACTICAL TOOLS GAVE THE INDUSTRY WAYS TO ADAPT TO MUCH-ANTICIPATED NEW GUIDANCE ON GOOD CLINICAL PRACTICE EARNING WIDE MEDIA COVERAGE ALONG THE WAY.- CLINICAL DATA SHARING: USAGE OF TRANSCELERATE'S DATACELERATE PLATFORM MORE THAN DOUBLED, DEMONSTRATING THE GROWING IMPACT OF DATA REUSE TO REDUCE BURDEN AND IMPROVE TRIAL DESIGN.- PATIENT SAFETY REPORTING: A MANUSCRIPT IN A PROMINENT JOURNAL AND DIALOGUE WITH MULTIPLE HEALTH AUTHORITIES MARKED CRUCIAL FIRST STEPS TOWARD MODERNIZING INDIVIDUAL CASE SAFETY REPORTING. - EMBEDDED PRAGMATIC TRIALS: TRANSCELERATE PUBLISHED A NEW RESOURCE GUIDE AND IN COLLABORATION WITH THE FDA RELEASED A PUBLIC SUMMARY OF A JOINT EXERCISE TO IDENTIFY ACTIONABLE OPPORTUNITIES TO SCALE THE USE OF PRAGMATIC ELEMENTS.TRANSCELERATE HEALTH AUTHORITY DIALOGUE EXPANDED ACROSS FOUR CONTINENTS WITH CONTINUED FOCUS ON PRODUCTIVE COLLABORATION. THE ORGANIZATION ALSO PARTNERED WITH A VARIETY OF OUTSIDE ORGANIZATIONS, INCLUDING WITH THE TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT (CSDD) TO PUBLISH A BENCHMARKING STUDY ON PROTOCOL COMPLEXITY.- TRANSCELERATE GLOBAL REACH AND PRESENCE EXPANDED IN 2025. HIGHLIGHTS INCLUDED HOSTING 8 PUBLIC WEBINARS REACHING 7,000+ PROFESSIONALS, COVERAGE IN 50+ PUBLICATIONS, AND PRESENTATIONS AT MORE THAN 20 CONFERENCES ACROSS NORTH AMERICA, EUROPE, ASIA, AND SOUTH AMERICA.THE ORGANIZATION'S WORK IN 2025 WAS AND WILL CONTINUE TO BE ORIENTED AROUND A VISION OF SEAMLESS CONVERGENCE OF RESEARCH AND CARE, SO THAT TRIAL PARTICIPATION BECOMES A NATURAL PART OF HEALTHCARE PROCESSES.
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(6) business league.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.
Are donations tax-deductible? Caution.
The IRS master file records contributions to this 501(c)(6) business league as not deductible.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending December 2025.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since June 2014.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.